Medicine and Dentistry
Antidiabetic Agent
33%
Cellular Mechanism
66%
Efficacy Study
33%
G Protein Coupled Receptor
33%
Gastric Inhibitory Polypeptide
66%
Glucagon Like Peptide 1
33%
Glucagon Like Peptide 1 Receptor
33%
Glucagon Receptor
33%
Guanine Nucleotide Binding Protein
33%
Incretin
100%
Insulin Like Activity
33%
Maturity Onset Diabetes of the Young
33%
Monotherapy
33%
Pancreatic Islet
100%
Peptide Receptor
66%
Receptor
100%
Signal Transduction
66%
Therapeutic Procedure
33%
Biochemistry, Genetics and Molecular Biology
Agonist
100%
Efficacy Study
50%
G Protein
50%
G Protein Coupled Receptor
50%
Glucagon Receptor
50%
Glucagon-Like Peptide 1 Receptor
50%
Glucagon-Like Peptide-1
50%
Incretin
100%
Insulin Like Activity
50%
Peptide Receptor
100%
Receptor Agonists
100%
Signal Transduction
100%
Neuroscience
Agonist
100%
Cell Signaling
66%
Eicosanoid Receptor
100%
G Protein
33%
G Protein Coupled Receptor
33%
Gastric Inhibitory Polypeptide
66%
Glucagon Receptor
33%
Glucagon-Like Peptide 1 Receptor
33%
Glucagon-Like Peptide-1
33%
Incretin
100%
Receptor Agonists
66%
Pharmacology, Toxicology and Pharmaceutical Science
Antidiabetic Agent
33%
Efficacy Study
33%
G Protein Coupled Receptor
33%
Gastric Inhibitory Polypeptide
66%
Glucagon Receptor
33%
Glucagon-Like Peptide 1 Receptor
33%
Glucagon-Like Peptide-1
33%
Guanine Nucleotide Binding Protein
33%
Incretin
100%
Monotherapy
33%
Non Insulin Dependent Diabetes Mellitus
33%
Receptor
100%
Receptor Agonist
66%